Richard J Haynes

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. pmc Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol
    Richard Haynes
    Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, Old Road Campus, Roosevelt Drive, Headington Oxford OX3 7LF, UK
    Transplant Res 2:7. 2013
  2. doi request reprint Myeloma kidney: improving clinical outcomes?
    Richard Haynes
    Oxford Kidney Unit, Churchill Hospital, Oxford, United Kingdom
    Adv Chronic Kidney Dis 19:342-51. 2012
  3. ncbi request reprint Reassuring results with regard to the effect of donor nephrectomy on cardiovascular outcomes
    Richard Haynes
    University of Oxford, Clinical Trial Service Unit, Oxford, UK
    Nat Clin Pract Nephrol 5:126-7. 2009
  4. doi request reprint Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre
    Richard J Haynes
    Oxford Kidney Unit, Churchill Hospital, Oxford, UK
    Nephrol Dial Transplant 25:419-26. 2010
  5. pmc Serum free light chains and the risk of ESRD and death in CKD
    Richard Haynes
    Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom
    Clin J Am Soc Nephrol 6:2829-37. 2011
  6. doi request reprint Simultaneous necrotizing glomerulonephritis and Hodgkin's lymphoma: a case report and review of the literature
    Thomas D Barbour
    Oxford Kidney Unit, Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK
    Nephrol Dial Transplant 26:3403-8. 2011
  7. doi request reprint Commentary: Controversies in NICE guidance on chronic kidney disease
    Martin J Landray
    Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford OX3 7LF
    BMJ 337:a1793. 2008
  8. doi request reprint Does prophylactic anticoagulation reduce the risk of femoral tunneled dialysis catheter-related complications
    William G Herrington
    Oxford Kidney Unit, Churchill Hospital, Oxford University Hospitals NHS Trust, Headington, Oxford, UK
    J Vasc Access 14:135-42. 2013

Collaborators

Detail Information

Publications8

  1. pmc Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol
    Richard Haynes
    Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, Old Road Campus, Roosevelt Drive, Headington Oxford OX3 7LF, UK
    Transplant Res 2:7. 2013
    ..CNI exposure could be minimized by using more potent induction therapy or alternative maintenance therapy to remove CNIs completely. However, the safety and efficacy of such strategies are unknown...
  2. doi request reprint Myeloma kidney: improving clinical outcomes?
    Richard Haynes
    Oxford Kidney Unit, Churchill Hospital, Oxford, United Kingdom
    Adv Chronic Kidney Dis 19:342-51. 2012
    ..Outcomes in patients with myeloma kidney do appear to be improving, but more trials are needed (some of which are in progress). There is cause for optimism for physicians and for patients suffering from this condition...
  3. ncbi request reprint Reassuring results with regard to the effect of donor nephrectomy on cardiovascular outcomes
    Richard Haynes
    University of Oxford, Clinical Trial Service Unit, Oxford, UK
    Nat Clin Pract Nephrol 5:126-7. 2009
    ....
  4. doi request reprint Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre
    Richard J Haynes
    Oxford Kidney Unit, Churchill Hospital, Oxford, UK
    Nephrol Dial Transplant 25:419-26. 2010
    ..Myeloma is the second most common haematological malignancy and is a cause of severe acute kidney injury (serum creatinine >or=500 micromol/L) that has long been associated with a poor prognosis, although previous series have been small...
  5. pmc Serum free light chains and the risk of ESRD and death in CKD
    Richard Haynes
    Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom
    Clin J Am Soc Nephrol 6:2829-37. 2011
    ..We aimed to prospectively study the relevance of the adaptive immune system to ESRD and mortality by measuring monoclonal and polyclonal excesses of highly sensitive serum free light chains (sFLCs)...
  6. doi request reprint Simultaneous necrotizing glomerulonephritis and Hodgkin's lymphoma: a case report and review of the literature
    Thomas D Barbour
    Oxford Kidney Unit, Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK
    Nephrol Dial Transplant 26:3403-8. 2011
    ..Two years later, recrudescent lymphadenopathy was shown to be Hodgkin's lymphoma, but renal disease did not recur...
  7. doi request reprint Commentary: Controversies in NICE guidance on chronic kidney disease
    Martin J Landray
    Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford OX3 7LF
    BMJ 337:a1793. 2008
  8. doi request reprint Does prophylactic anticoagulation reduce the risk of femoral tunneled dialysis catheter-related complications
    William G Herrington
    Oxford Kidney Unit, Churchill Hospital, Oxford University Hospitals NHS Trust, Headington, Oxford, UK
    J Vasc Access 14:135-42. 2013
    ....